Annual accounts
Small accounts
31/01/2027Filing deadline
Made up to 30/04/2025Due 31/01/2027
- Next accounts made up to
- 30/04/2026
- Last accounts made up to
- 30/04/2025
NRG THERAPEUTICS LTD
Active- 11294505Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts SG1 2FX
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Small
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 07/09/2026View PDF (1 pages)
Termination of appointment of Florian Muellershausen as a director on 2026-09-01
- 07/09/2026View PDF (2 pages)
Appointment of Mathias Ugelstad Frederiksen as a director on 2026-09-01
- 04/08/2026View PDF (6 pages)
Replacement filing of SH01 - 14/05/24 Statement of Capital gbp 5340.182
- 28/07/2026View PDF (8 pages)
Replacement Filing of Confirmation Statement dated 2026-04-04
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 04/04/2026
- Last statement dated
- 30/04/2025
Financial performance
The latest figures NRG THERAPEUTICS LTD filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£2.28M2025
-53.63%vs 20242024: £4.91M
Total Assets
£4.47M2025
-33.34%vs 20242024: £6.71M
Cash in Bank
£3.56M2025
-32.26%vs 20242024: £5.25M
Total Liabilities
£2.19M2025
22.17%vs 20242024: £1.79M
Employees
72025
+1vs 20242024: 6
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Net assets moved furthest, down 53.63% on 2024. See the full financial analysis for NRG THERAPEUTICS LTD.
The full financial record
Four ways through NRG THERAPEUTICS LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -57% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 7 | +1 |
| 2024 | 6 | -1 |
| 2023 | 7 | +2 |
| 2022 | 5 | 0 |
| 2021 | 5 | – |
Reported employee count increased from 5 in 2021 to 7 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
17Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 05/04/2018–27/06/2019 | 21 | |
| Director | 05/11/2019–30/06/2022 | 7 | |
| Director | 05/04/2018–Present | 4 | |
| Director | 05/04/2018–27/06/2019 | 5 | |
| Director | 30/06/2022–19/10/2023 | 10 | |
| Director | 02/07/2025–02/02/2026 | 5 | |
| Director | 30/06/2022–Present | 0 | |
| Director | 30/06/2022–Present | 0 | |
| Director | 27/06/2019–02/07/2025 | 0 | |
| Secretary | 02/12/2022–Present | 0 | |
| Director | 06/04/2023–Present | 4 | |
| Director | 02/07/2025–10/12/2025 | 8 | |
| Director | 19/10/2023–02/07/2025 | 0 | |
| Director | 02/07/2025–01/09/2026 | 0 | |
| Director | 22/08/2025–Present | 0 | |
| Director | 02/02/2026–Present | 0 | |
| Director | 01/09/2026–Present | 0 |
Persons with significant control
7Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 27/06/2019–27/06/2019 | 1 | |
| 05/04/2018–30/06/2022 | 21 | |
| 05/04/2018–30/06/2022 | 4 | |
| 05/04/2018–30/06/2022 | 5 | |
| 26/06/2019–01/07/2022 | 0 | |
| 26/06/2019–Present | 0 | |
| 07/07/2022–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 48 Since 17/10/2022
- Last 12 months
- 10 -10 vs the year before
- Most recent filing
- 07/09/2026 less than a month ago
What changed in the last year
- Officer changes (5)Latest 07/09/2026
- Share capital (3)Latest 04/08/2026
- Confirmation statementLatest 28/07/2026
- Accounts filedLatest 13/10/2025
Filing timeline
- 07/09/2026View PDF (1 pages)
Termination of appointment of Florian Muellershausen as a director on 2026-09-01
- 07/09/2026View PDF (2 pages)
Appointment of Mathias Ugelstad Frederiksen as a director on 2026-09-01
- 04/08/2026View PDF (6 pages)
Replacement filing of SH01 - 14/05/24 Statement of Capital gbp 5340.182
- 28/07/2026View PDF (8 pages)
Replacement Filing of Confirmation Statement dated 2026-04-04
- 19/04/2026View PDF (11 pages)
04/04/26 Statement of Capital gbp 11791.794
- 24/02/2026View PDF (7 pages)
Statement of capital following an allotment of shares on 2026-02-24
- 04/02/2026View PDF (2 pages)
Appointment of Georgia Rose Frost as a director on 2026-02-02
- 04/02/2026View PDF (1 pages)
Termination of appointment of Laurence Daniel Paul Barker as a director on 2026-02-02
- 12/12/2025View PDF (1 pages)
Termination of appointment of Emma Johnson as a director on 2025-12-10
- 13/10/2025View PDF (12 pages)
Accounts for a small company made up to 2025-04-30
- 28/08/2025View PDF (1 pages)
Resolutions
- 28/08/2025View PDF (72 pages)
Memorandum and Articles of Association
Showing 12 of 48 filings
See when the next accounts and confirmation statement are due
Similar companies
84 UK companies are similar to NRG THERAPEUTICS LTD, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
ELIPTICA LIMITED
Active2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB
- Activity
- Research and experimental development on biotechnology
- Company no.
- 14041502
- Incorporated
- 12/04/2022
- Employees
- 5
LAMBDA ENERGY LTD
ActiveAllia Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11246890
- Incorporated
- 10/03/2018
- Employees
- 5
AKL RESEARCH & DEVELOPMENT LIMITED
ActiveThe Lexicon Second Floor, Mount Street, Manchester M2 5NT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 08699350
- Incorporated
- 20/09/2013
- Employees
- 5
ADDIBLE LTD
ActiveSpitfire House 19 Falcon Court, Preston Farm Industrial Estate, Stockton-On-Tees TS18 3TU
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12633636
- Incorporated
- 30/05/2020
- Employees
- 7
AMPERSAND HEALTH LIMITED
Active76 Portland Place, London W1B 1NT
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11584266
- Incorporated
- 24/09/2018
- Employees
- 5
About NRG THERAPEUTICS LTD
A short description of the company, written from its Companies House record.
NRG THERAPEUTICS LTD is a private limited company registered in the United Kingdom, based in Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts SG1 2FX. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 8 years 5 months.
The register currently records it as active. Its 2025 accounts report net assets of £2.28M and 7 employees.
NRG THERAPEUTICS LTD: frequently asked questions
Answered from this company's own registry record and filed figures.
What does NRG THERAPEUTICS LTD do?
Companies House records NRG THERAPEUTICS LTD under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is NRG THERAPEUTICS LTD still active?
NRG THERAPEUTICS LTD is recorded as active on the Companies House register, and has been on it since 05/04/2018.
What are NRG THERAPEUTICS LTD's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £2.28M, total assets of £4.47M, cash in bank of £3.56M and total liabilities of £2.19M.
When did NRG THERAPEUTICS LTD last file with Companies House?
The most recent document on the record is dated 07/09/2026: Termination of appointment of Florian Muellershausen as a director on 2026-09-01, less than a month ago.
When are NRG THERAPEUTICS LTD's next filings due?
On the current registry record, accounts are due by 31/01/2027.
Who runs NRG THERAPEUTICS LTD?
Companies House lists 17 officers (8 currently in post) and 7 people with significant control (2 current).